- Industry
- Financial services
- Organization
- J.P. Morgan Asset Management
- Berkan Sesen’s role
- Senior quantitative portfolio manager and fund co-manager
- When
- 2017-2021
The business need
A thematic fund depends on finding the listed companies most exposed to a theme. J.P. Morgan Asset Management announced its Genetic Therapies fund in Europe in November 2019 to give investors diversified exposure to that theme.
The evidence for exposure sits in a very large body of text: news articles, company profiles, research notes and regulatory filings, across more than 10,000 stocks worldwide.
What Berkan Sesen did
- Berkan worked as a research analyst and portfolio manager in the firm's Quantitative Beta Strategies group, a team that builds machine-learning based investment technology.
- The team's thematic engine, ThemeBot, used natural language processing to screen more than 10,000 stocks and flag those most exposed to a theme, accounting for liquidity, market capitalization and profitability.
- The funds' methodology, which ranks companies by combining a textual relevance score with a revenue exposure score, was filed as a US patent application in 2020, with Berkan as a named inventor.
- Before any stock entered the portfolio, the team and the firm's equity analysts vetted and validated the engine's selections.
- Berkan co-managed the Genetic Therapies fund with two other portfolio managers; the fund drew on research by the UBS Global Wealth Management Chief Investment Office and was distributed through UBS initially.
- Berkan also co-developed the News Filter, a machine learning and natural language processing system built at J.P. Morgan Asset Management.
Technology and approach
- Natural language processing over news articles, company profiles, research notes and regulatory filings
- Composite scoring of textual relevance and revenue exposure (US patent application US20200320633, filed 2020)
- A convolutional neural network that classifies publications by relevance, trained on manually labeled examples (a separate JPMorgan patent application, US20200142962, filed 2018, with Berkan as a named inventor)
Outcome
- The Genetic Therapies fund was announced as J.P. Morgan Asset Management's first actively managed fund combining machine learning and active equity insights.
- The machine-learning thematic funds reached more than $2bn in combined assets under management.
- The News Filter won at the Banking Technology Awards UK and the American Financial Technology Awards in 2017, according to Berkan's site.
Decisions this experience speaks to
- Where does AI actually earn its place in this product, and where are we just chasing the hype?
- We're being told the model performs well. How do we know that number is real and not an artefact of how it was tested?
Related services and use cases
Sources
- Berkan Sesen’s profile on CTO Grand Rounds
- Fund launch announcement - Funds Society (opens in a new tab)
- Berkan Sesen bio - J.P. Morgan Asset Management (opens in a new tab)
- Thematic portfolio patent application - Google Patents (opens in a new tab)
- Content filtering patent application - Google Patents (opens in a new tab)
- Berkan's experience and awards - sesen.ai (opens in a new tab)
This case describes Berkan Sesen’s own work before Grand Rounds, as Berkan Sesen’s profile and the public sources above describe it. It is not a Grand Rounds engagement and not a promise of the same result for another company.